Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption.
about
Siglec-mediated regulation of immune cell function in disease.Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.Sequential activation of the AKT pathway in human osteoblasts treated with Oscarvit: a bioactive product with positive effect both on skeletal pain and mineralization in osteoblasts.Cell-based glycan arrays for probing glycan-glycan binding protein interactions.
P2860
Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanism and function of mono ...... osteoclastic bone resorption.
@en
Mechanism and function of mono ...... osteoclastic bone resorption.
@nl
type
label
Mechanism and function of mono ...... osteoclastic bone resorption.
@en
Mechanism and function of mono ...... osteoclastic bone resorption.
@nl
prefLabel
Mechanism and function of mono ...... osteoclastic bone resorption.
@en
Mechanism and function of mono ...... osteoclastic bone resorption.
@nl
P2093
P2860
P356
P1476
Mechanism and function of mono ...... osteoclastic bone resorption.
@en
P2093
Aida Kalbakji
Anna Moraitis
Annie Fortin
Gilles B Tremblay
Mario Filion
Matthew Stuible
Stefan Saragosa
P2860
P304
P356
10.1074/JBC.M113.494542
P407
P577
2014-01-20T00:00:00Z